| Overall cohort | Excluded cases | Study population |
---|---|---|---|
N | 207 | 27 | 180 |
Males/Females | 59.4% 40.6% | 59.3% 40.7% | 59.4% 40.6% |
Age median (yrs) (min-max) | 69 (18–90) | 67 (32–90) | 69 (18–90) |
RRT vintage (yrs) (min-max) | 6.4 (0.2–43.5) | 3.2 (0.2–24.6) | 6.7 (0.07–43.5) |
Charlson median (min-max) | 8 (2–16) | 7 (2–14) | 8 (2–16) |
MIS median (min-max) | 7 (1–27) | 9.5 (1–27) | 7 (1–27) |
SGA: A | 58.0% | 37.0% | 61.1% |
B | 32.9% | 25.9% | 33.9% |
C | 6.8% | 18.5% | 5.0% |
HD-HDF (%) | HD: 33.9% HDF: 66.1% | HD: 59.3% HDF: 40.7% | HD: 40.0% HDF: 60.0% |
BMI Kg/m2 median (min-max) | 24.2 (14.6–47.1) | 22.8 (16.6–43.4) | 24.3(14.6–47.1) |
BMI < 20 | 41 (20.0%) | 9 (33.3%) | 32 (18.0%) |
BMI 20–25 | 75 (36.6%) | 9 (33.3%) | 66 (37.1%) |
BMI 25–30 | 62 (30.2%) | 6 (22.2%) | 56 (31.5%) |
BMI > = 30 | 27 (13.2%) | 3 (11.1%) | 24 (13.5%) |
Albumin (g/dl) median (min-max) | 3.4 (1.9–4.5) | 3.4 (1.9–4.1) | 3.4 (2.0–4.5) |
Albumin < 3 | 28 (13.6%) | 5 (19.2%) | 23 (12.8%) |
Albumin < 3.5 | 114 (55.3%) | 15 (57.7%) | 99 (55.0%) |
BUN (mg/dl) median (min-max) | 60.5 (24.4–118) | 66.7 (26.0–118) | 60.0 (24.4–105) |
Creatinine (mg/dl) median (min-max) | 8.9 (1.9–15.0) | 6.9 (1.9–12.6) | 9.1 (2.7–15.0) |
Cholesterol (mg/dl) median (min-max) | 162.2 (49–438) | 182.1 (117–438) | 158 (49–263) |
Kt/V median (min-max) | 1.6 (0.7–2.3) | 1.4 (0.8–2.2) | 1.6 (0.7–2.3) |
nPCR (g/Kg/day) median (min-max) | 1.0 (0.5–1.9) | 0.9 (0.5–1.9) | 1.04 (0.5–1.8) |